Goal 2: Reduce Human Disease

Phase III efficacy trials of tuberculosis drugs

1) Phase III efficacy trials of new tuberculosis drugs (e.g., bedaquiline, delamanid, PA-824) that have shown promise in early phase studies for multidrug-resistant tuberculosis.

 

2) Phase III efficacy trials of new and existing tuberculosis drugs to development very short course regimens (3-4 months).

 

3) Phase III efficacy trials of new and existing drugs for treatment of latent tuberculosis infection in contacts of persons with multidrug-resistant tuberculosis.

Is this idea a Compelling Question (CQ) or Critical Challenge (CC)? Critical Challenge (CC)

Name of idea submitter and other team members who worked on this idea American Thoracic Society member

Tags (Keywords associated with the idea)

Annotations

Voting

1 net vote
1 up votes
0 down votes
Active
Idea No. 1623